It is commonly caused by loss-of-function mutations in LDLR, mutations in APOB, or less-frequent gain-of-function mutations within PCSK9. FH is clinically diagnosed based on serum cholesterol levels, physical examinations, and family history. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.